Community-Acquired Pneumonia

1. Front Matter

   Pages i-xxviii

   PDF

2. The Captain of the Men of Death

   • Jock Murray

   Pages 1-12

3. Epidemiology of Community-Acquired Pneumonia

   • IIrma Helena Koivula

   Pages 13-27

4. Clinical Features and Outcomes of Community-Acquired Pneumonia

   • Thomas J. Marrie

   Pages 29-34

5. Laboratory Diagnosis of Community-Acquired Pneumonia

   • Rpss J. Davidson, Kelly S. Macdonald

   Pages 35-43

6. Polymerase Chain Reaction Techniques in the Diagnosis of Pneumonia

   • Barry S. Fields

   Pages 45-54

7. Imaging Community-Acquired Pneumonia

   • Gerry Schaller, Mark Logan

   Pages 55-100

8. The Pathology of Community-Acquired Pneumonia

   • Claudia Molina, David H. Walker

   Pages 101-129

9. Etiology of Community-Acquired Pneumonia

   • Thomas J. Marrie

   Pages 131-141

10. Nursing Home-Acquired Pneumonia

    • Andrew E. Simor

    Pages 143-162

11. Treatment of Community-Acquired Pneumonia

    • Mark Woodhead

    Pages 163-178

12. Pathophysiology of Pneumonia and the Clinical Consequences

    • Ward Patrick

    Pages 179-192

13. Intensive Care Unit Management of Pneumonia

    • Thomas J. Nolan, David G. McCormack

    Pages 193-204

14. End-of-life Decision-making in Community-Acquired Pneumonia

    • Kenneth Rockwood, Colin Powell

    Pages 205-220

15. Prevention of Community-Acquired Pneumonia

    • Jay C. Butler, Keiji Fukuda, Robert F. Breiman

    Pages 221-238

16. Aspiration Pneumonia

    • Marcio Sa-Borges, Jordi Rello

    Pages 239-255

17. Complicated Pleural Effusion in Community-Acquired Pneumonia

    • Richard W. Light

    Pages 257-271

18. A Critical Pathway for the Treatment of Community-Acquired Pneumonia

    • Thomas J. Marrie

    Pages 273-281

19. Pneumonia in Pregnancy

    • Joanne M. Langley

    Pages 283-291

20. Pneumonia in Children and Adolescents

    • Elaine E. Wang, Herbert Dele Davoes

    Pages 293-303

Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly from one geographic area to the next, and the scientific basis for many of our management strategies for pneumonia is weak to nonexistent. There are over 100 microbial agents that can cause pneumonia and many of these, especially Streptococcus pneumoniae, Group A streptococcus, and Staphylococcus aureus, are in a state of flux in terms of changing antimicrobial resistance. This book is designed to provide new information about pneumonia and identify critical research questions that will come to the fore as we enter the 21st century.

• Atmen
• HIV
• Virus
• antimicrobial
• antimicrobial resistance
• antimicrobial therapy
• bacteria
• infectious diseases

• University of Alberta, Edmonton, Canada

  Thomas J. Marrie

Policies and ethics